Cost‐effectiveness analysis of a digital diabetes‐prevention programme versus an in‐person diabetes‐prevention programme in people with prediabetes in the United States
Diabetes, Obesity and Metabolism · 2024-10 · 26 (10) · 4522-4534
DOI: 10.1111/dom.15807 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Diabetes, Obesity and Metabolism, online erschienen am 26.07.2024. Verfasst von Sooyeol Park und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Policy and Management, Tulane University School of Public Health and Tropical Medicine, New Orleans, Louisiana, USA. Hauptthemen laut MEDLINE: Cost-Benefit Analysis, Prediabetic State, Diabetes Mellitus, Type 2, Quality-Adjusted Life Years. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Aim
To assess the cost‐effectiveness of a digital diabetes prevention programme (d‐DPP) compared with a diabetes prevention programme (DPP) for preventing type 2 diabetes (T2D) in individuals with prediabetes in the United States.
Methods
A Markov cohort model was constructed, simulating a 10‐year period starting at the age of 45 years, with a societal and healthcare sector perspective. The effectiveness of the d‐DPP intervention was evaluated using a meta‐analysis, with that of the DPP as the comparator. The initial cycle represented the treatment period, and transition probabilities for the post‐treatment period were derived from a long‐term lifestyle intervention meta‐analysis. The onset of T2D complications was estimated using microsimulation. Quality‐adjusted life years (QALYs) were calculated based on health utility measured by short form (SF)‐12 scores, and a willingness‐to‐pay threshold of $100 000 per QALY gained was applied.
Results
The d‐DPP intervention resulted in cost savings of $3,672 from a societal perspective and $2,990 from a healthcare sector perspective and a gain of 0.08 QALYs compared with the DPP. The dropout rate was identified as a significant factor influencing the results. Probabilistic sensitivity analysis showed that the d‐DPP intervention was preferred in 85.8% in the societal perspective and 85.2% in the healthcare sector perspective.
Conclusions
The d‐DPP is a cost‐effective alternative to in‐person lifestyle interventions for preventing the development of T2D among individuals with prediabetes in the United States.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Health Policy and Management, Tulane University School of Public Health and Tropical Medicine, New Orleans, Louisiana, USA.
- Department of Health Policy and Management, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, North Carolina, USA.
- Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
ORCID-Profile: Sooyeol Park, Lizheng Shi
Zitieren
APA
Park, S., Ballreich, J., Ward, T., & Shi, L. (2024). Cost‐effectiveness analysis of a digital diabetes‐prevention programme versus an in‐person diabetes‐prevention programme in people with prediabetes in the United States. Diabetes, Obesity and Metabolism, 26(10), 4522-4534. https://doi.org/10.1111/dom.15807
Vancouver
Park S, Ballreich J, Ward T, Shi L. Cost‐effectiveness analysis of a digital diabetes‐prevention programme versus an in‐person diabetes‐prevention programme in people with prediabetes in the United States. Diabetes, Obesity and Metabolism. 2024;26(10):4522-4534. doi:10.1111/dom.15807
BibTeX
@article{Park2024,
author = {Park, Sooyeol and Ballreich, Jeromie and Ward, Trevor and Shi, Lizheng},
title = {Cost‐effectiveness analysis of a digital diabetes‐prevention programme versus an in‐person diabetes‐prevention programme in people with prediabetes in the United States},
journal = {Diabetes, Obesity and Metabolism},
year = {2024},
volume = {26},
number = {10},
pages = {4522--4534},
doi = {10.1111/dom.15807}
}
EUVIMED